ASS1 and non-small cell lung carcinoma: Additionally, we sought to translate the correlative molecular biomarkers of ASS1 deficiency in non‐squamous NSCLC by next‐generation sequencing, characterize the levels of PD‐L1 expression immunohistochemically, and explore the treatment resistance.